| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 29 |
| 1 | UPADACITINIB | 24 |
| 2 | RISANKIZUMAB-RZAA | 16 |
| 3 | IBRUTINIB | 15 |
| 4 | ALBUTEROL SULFATE | 12 |
| 5 | ESOMEPRAZOLE MAGNESIUM | 9 |
| 6 | INTERFERON BETA-1A | 9 |
| 7 | METFORMIN | 9 |
| 8 | METFORMIN ER 500 MG | 9 |
| 9 | METFORMIN ER 750 MG | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LAROTRECTINIB | 1 | 0.0011 |
| 1 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 1 | 0.0008 |
| 2 | EPCORITAMAB-BYSP | 1 | 0.0007 |
| 3 | SODIUM SULFATE, MAGNESIUM SULFATE, AND POTASSIUM CHLORIDE | 1 | 0.0006 |
| 4 | LANADELUMAB-FLYO | 2 | 0.0006 |
| 5 | TESAMORELIN | 1 | 0.0006 |
| 6 | GOLIMUMAB | 6 | 0.0005 |
| 7 | C1 ESTERASE INHIBITOR RECOMBINANT | 3 | 0.0005 |
| 8 | LEBRIKIZUMAB-LBKZ | 1 | 0.0004 |
| 9 | TIOPRONIN | 1 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Janus Kinase Inhibitor [EPC] | 24 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 21 |
| 2 | Kinase Inhibitor [EPC] | 20 |
| 3 | Interleukin-23 Antagonist [EPC] | 17 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 15 |
| 5 | Benzodiazepine [EPC] | 11 |
| 6 | Corticosteroid [EPC] | 11 |
| 7 | Atypical Antipsychotic [EPC] | 10 |
| 8 | Interferon beta [EPC] | 9 |
| 9 | Vitamin B12 [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Adrenocorticotropic Hormone [EPC] | 1 | 0.0011 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 3 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 4 | Reducing and Complexing Thiol [EPC] | 1 | 0.0004 |
| 5 | Interleukin-13 Antagonist [EPC] | 2 | 0.0003 |
| 6 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 2 | 0.0003 |
| 7 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 8 | Provitamin D2 Compound [EPC] | 7 | 0.0002 |
| 9 | Hepatitis C Virus NS3/4A Protease Inhibitor [EPC] | 3 | 0.0002 |